Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Interferon-alpha/administration & dosage"" wg kryterium: Temat


Wyświetlanie 1-13 z 13
Tytuł :
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms:minimal residual disease and cure?
Autorzy :
Hasselbalch, Hans Carl
Holmström, Morten Orebo
Pokaż więcej
Temat :
Protein Kinase Inhibitors/administration & dosage
Inflammation/diagnosis
Cure
Disease Progression
DNA-hypomethylator
Polycythemia Vera/diagnosis
hemic and lymphatic diseases
Inflammation
Review
Pegylated interferon-alpha2
Combination therapy
MPNs
Ruxolitinib
MRD
Myeloproliferative neoplasms
Myeloproliferative Disorders/diagnosis
Immunologic Surveillance
MPN
Treatment Outcome
Mutation
Vaccination strategies
Neoplasm, Residual
Statins
Minimal residual disease
Journal Article
Humans
Interferon-alpha/administration & dosage
Źródło :
Seminars in Immunopathology
Hasselbalch, H C & Holmström, M O 2019, ' Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms : minimal residual disease and cure? ', Seminars in Immunopathology, vol. 41, no. 1, pp. 5-19 . https://doi.org/10.1007/s00281-018-0700-2
Opis pliku :
application/pdf
Tytuł :
A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1
Autorzy :
Donskov, Frede
Jensen, Niels Viggo
Smidt-Hansen, Torben
Brøndum, Line
Geertsen, Poul
Pokaż więcej
Temat :
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Kaplan-Meier Estimate
Aged
Middle Aged
Treatment Outcome
Interleukin-2/administration & dosage
Disease-Free Survival
Recombinant Proteins/administration & dosage
Kidney Neoplasms/drug therapy
Bevacizumab/administration & dosage
Adult
Female
Humans
Carcinoma, Renal Cell/drug therapy
Male
Interferon-alpha/administration & dosage
Źródło :
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC) : results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Donskov, F, Jensen, N V, Smidt-Hansen, T, Brøndum, L & Geertsen, P 2018, ' A randomized phase II trial of interleukin-2 and interferon-α plus bevacizumab versus interleukin-2 and interferon-α in metastatic renal-cell carcinoma (mRCC): results from the Danish Renal Cancer Group (DaRenCa) study-1 ', Acta Oncologica, vol. 57, no. 5, pp. 589-594 . https://doi.org/10.1080/0284186X.2018.1433324
Opis pliku :
application/pdf
Tytuł :
Interferon α kinoid induces neutralizing anti-interferon α antibodies that decrease the expression of interferon-induced and B cell activation associated transcripts: analysis of extended follow-up data from the interferon α kinoid phase I/II study
Autorzy :
Ducreux, Julie
Houssiau, Frédéric
Vandepapeliere, Pierre
Jorgensen, Christian
Lazaro, Estibaliz
Spertini, Francois
Colaone, Fabien
Roucairol, Camille
Laborie, Marion
Croughs, Thérèse
Grouard-Vogel, Géraldine
Lauwerys, Bernard
Pokaż więcej
Temat :
Basic Science
systemic lupus erythematosus
B cells
interferon alpha kinoid
interferon signature
[ SDV.MHEP.RSOA ] Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
interferon alpha
Adolescent
Adult
Anti-Inflammatory Agents/administration & dosage
Antibodies, Neutralizing/immunology
B-Lymphocytes/immunology
Dose-Response Relationship, Drug
Double-Blind Method
Female
Follow-Up Studies
Humans
Interferon-alpha/administration & dosage
Interferon-alpha/immunology
Lupus Erythematosus, Systemic/drug therapy
Lupus Erythematosus, Systemic/immunology
Lymphocyte Activation/immunology
Male
Middle Aged
Recombinant Proteins/administration & dosage
Young Adult
[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system
Źródło :
Rheumatology (Oxford, England)
Rheumatology, Oxford University Press (OUP), 2016, 55 (10), pp.1901 - 1905. ⟨10.1093/rheumatology/kew262⟩
Rheumatology, Oxford University Press (OUP), 2016, 55 (10), pp.1901 - 1905. 〈10.1093/rheumatology/kew262〉
Rheumatology (Oxford, England), vol. 55, no. 10, pp. 1901-1905
Opis pliku :
application/pdf
Tytuł :
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection
Autorzy :
Laird, Melissa E.
Mohsen, Amira
Duffy, Darragh
Mamdouh, Rasha
LeFouler, Lenaig
Casrouge, Armanda
El-Daly, Mai
Rafik, Mona
MOHAMED, Mohamed
Soulier, Alexandre
Pawlotsky, Jean-Michel
Hézode, Christophe
Rosa, Isabelle
Renard, Philippe
Mohamed, Mostafa K.
Bonnard, Philippe
Izopet, Jacques
Mallet, Vincent
Pol, Stanislas
Albert, Matthew L.
Fontanet, Arnaud
Pokaż więcej
Temat :
Hepatitis C virus
Quantitative trait loci
Lipid metabolism
Apolipoproteins
IL28B
MESH: Adult
MESH: Aged
MESH: Hepatitis C*/complications Hepatitis
MESH: C*/drug therapy Hepatitis
MESH: C*/genetics Hepatitis
MESH: C*/immunology Hepatitis
MESH: C*/physiopathology Humans
MESH: Interferon-alpha/administration & dosage
MESH: Interleukins/genetics
MESH: Male
MESH: Middle Aged
MESH: Polyethylene Glycols/administration & dosage
MESH: Antiviral Agents/administration & dosage
MESH: Polymorphism, Single Nucleotide
MESH: Ribavirin/administration & dosage
MESH: Treatment Outcome
MESH: Viral Load
MESH: Virus Replication/drug effects
MESH: beta 2-Glycoprotein I*/blood
MESH: beta 2-Glycoprotein I*/genetic
MESH: Coinfection
MESH: Female
MESH: HIV Infections*/complications
MESH: HIV Infections*/drug therapy
MESH: HIV Infections*/immunology
MESH: Hepacivirus*/drug effects
MESH: Hepacivirus*/physiology
[SDV.IMM]Life Sciences [q-bio]/Immunology
Źródło :
Journal of Hepatology, Elsevier, 2014, 61 (4), pp.770 - 776. ⟨10.1016/j.jhep.2014.05.040⟩
Tytuł :
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection
Autorzy :
Laird, Melissa E.
Mohsen, Amira
Duffy, Darragh
Mamdouh, Rasha
LeFouler, Lenaig
Casrouge, Armanda
El-Daly, Mai
Rafik, Mona
MOHAMED, Mohamed
Soulier, Alexandre
Pawlotsky, Jean-Michel
Hézode, Christophe
Rosa, Isabelle
Renard, Philippe
Mohamed, Mostafa K.
Bonnard, Philippe
Izopet, Jacques
Mallet, Vincent
Pol, Stanislas
Albert, Matthew L.
Fontanet, Arnaud
Pokaż więcej
Temat :
MESH: Interleukins/genetics
MESH: Hepacivirus*/physiology
MESH: Viral Load
MESH: Male
MESH: Treatment Outcome
MESH: Aged
MESH: Interferon-alpha/administration & dosage
[SDV.IMM]Life Sciences [q-bio]/Immunology
Lipid metabolism
MESH: Antiviral Agents/administration & dosage
Quantitative trait loci
MESH: Ribavirin/administration & dosage
MESH: Female
MESH: Adult
MESH: C*/physiopathology Humans
MESH: HIV Infections*/complications
MESH: HIV Infections*/drug therapy
IL28B
Apolipoproteins
MESH: C*/genetics Hepatitis
MESH: Virus Replication/drug effects
MESH: C*/immunology Hepatitis
MESH: Hepacivirus*/drug effects
MESH: HIV Infections*/immunology
Hepatitis C virus
MESH: Polyethylene Glycols/administration & dosage
MESH: Polymorphism, Single Nucleotide
MESH: beta 2-Glycoprotein I*/genetic
MESH: Middle Aged
MESH: Hepatitis C*/complications Hepatitis
MESH: C*/drug therapy Hepatitis
MESH: Coinfection
MESH: beta 2-Glycoprotein I*/blood
Źródło :
Journal of Hepatology, Elsevier, 2014, 61 (4), pp.770 - 776. ⟨10.1016/j.jhep.2014.05.040⟩
Journal of Hepatology; Vol 61
Tytuł :
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection
Autorzy :
Laird, Melissa E.
Mohsen, Amira
Duffy, Darragh
Mamdouh, Rasha
LeFouler, Lenaig
Casrouge, Armanda
El-Daly, Mai
Rafik, Mona
MOHAMED, Mohamed
Soulier, Alexandre
Pawlotsky, Jean-Michel
Hézode, Christophe
Rosa, Isabelle
Renard, Philippe
Mohamed, Mostafa K.
Bonnard, Philippe
Izopet, Jacques
Mallet, Vincent
Pol, Stanislas
Albert, Matthew L.
Fontanet, Arnaud
Pokaż więcej
Temat :
Hepatitis C virus
Quantitative trait loci
Lipid metabolism
Apolipoproteins
IL28B
MESH: Adult
MESH: Aged
MESH: Hepatitis C*/complications Hepatitis
MESH: C*/drug therapy Hepatitis
MESH: C*/genetics Hepatitis
MESH: C*/immunology Hepatitis
MESH: C*/physiopathology Humans
MESH: Interferon-alpha/administration & dosage
MESH: Interleukins/genetics
MESH: Male
MESH: Middle Aged
MESH: Polyethylene Glycols/administration & dosage
MESH: Antiviral Agents/administration & dosage
MESH: Polymorphism, Single Nucleotide
MESH: Ribavirin/administration & dosage
MESH: Treatment Outcome
MESH: Viral Load
MESH: Virus Replication/drug effects
MESH: beta 2-Glycoprotein I*/blood
MESH: beta 2-Glycoprotein I*/genetic
MESH: Coinfection
MESH: Female
MESH: HIV Infections*/complications
MESH: HIV Infections*/drug therapy
MESH: HIV Infections*/immunology
MESH: Hepacivirus*/drug effects
MESH: Hepacivirus*/physiology
[SDV.IMM]Life Sciences [q-bio]/Immunology
Źródło :
Journal of Hepatology, Elsevier, 2014, 61 (4), pp.770 - 776. ⟨10.1016/j.jhep.2014.05.040⟩
Tytuł :
IL-2+IFN-α併用療法が著効した腎細胞癌肺転移の1例
Successful treatment for renal cell carcinoma with lung metastases by interleukin-2 and interferon-alfa: a case report
Autorzy :
坂田, 裕子
小倉, 友二
脇田, 利明
林, 宣男
杉村, 芳樹
Pokaż więcej
Temat :
Aged
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Carcinoma, Renal Cell/drug therapy/secondary/surgery
Combined Modality Therapy
Humans
Interferon-alpha/administration & dosage
Interleukin-2/administration & dosage
Kidney Neoplasms/drug therapy/pathology/surgery
Lung Neoplasms/drug therapy/secondary
Male
Nephrectomy
Źródło :
泌尿器科紀要. 49
Opis pliku :
application/pdf
Tytuł :
孤立性対側副腎転移を伴った腎細胞癌の1例
A case of renal cell carcinoma with solitary metastasis to the contralateral adrenal gland
Autorzy :
新井, 学
釜井, 隆男
長本, 章裕
斎藤, 和男
広川, 信
Pokaż więcej
Temat :
Adrenal Gland Neoplasms/secondary/therapy
Adrenalectomy
Carcinoma, Renal Cell/secondary/therapy
Female
Humans
Interferon-alpha/administration & dosage
Kidney Neoplasms/pathology/therapy
Middle Aged
Nephrectomy
Źródło :
泌尿器科紀要. 43
Opis pliku :
application/pdf
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies